Arogya rakshak panchatantra for dysmenorrhoea

"Effect of Arogya Raksha Panchatantra (five lifestyle principles) on Heart rate variability, Health related quality of life, performance and self-efficacy in Young female adults with primary dysmenorrhea. A Randomized control trial, Version 1.0"

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047041

Enrollment

Registered

2022-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N711- Chronic inflammatory disease of uterus

Interventions

Intervention1: Arogya Rakshak Panchatantra: Eat twice a day Drink at least 2 seers (8-10) glasses of water in a day Exercise daily for 1 hour Fasting once in a week Prayers twice a day Interventio

Eligibility

Inclusion criteria

Inclusion criteria: Regular menstrual cycle with cycle duration between 25-40 days Vas score for pain >3 (at the time of screening) No medical history of any gynecological diseases Not taking any hormonal treatments Nullipara • Normal BMI (18-25) • Those willing to give informed consent

Exclusion criteria

Exclusion criteria: Participants with any known history of any systemic pathology Menorrhagia Habitual smoking, addiction Those taking OCPs or any hormonal medications BMI >25 and

Design outcomes

Primary

Measure	Time frame
To study the effects of Arogya Raksha Panchatantra (basic five lifestyle principles) on autonomic flexibility using Heart rate variability (HRV).Timepoint: Heart rate variability will be taken at baseline( 0 weeks ) , then 4 weeks, 8 weeks , 12 weeks and after 6 months	—

Secondary

Measure	Time frame
To study the long-term association between dysmenorrhea and HRV To study the impact of Arogya Raksha Panchatantra on primary dysmenorrhoea symptoms using a retrospective symptom scale (RSS). To study the effects of the basic five lifestyle principles on quality of life using the SF-12 health questionnaire. To study the effects of the basic five lifestyle principles on self-efficacy using a Generalized self-efficacy questionnaire. To study the effects of the basic five lifestyle principles on sleep quality and daytime performance using the Epworth daytime sleepiness scale. To document enduring health benefits of the basic five lifestyle principles in absenteeism, frequency of illness, academic performance among the study participants. To understand the adherence of the study participants to arogya raksha panchatantras. Timepoint: SF12, RSS, sleep scale, Efficacy questionnaire will be measured at baseline , after 3 months of intervention and at 6 months follow up Self-reported VAS, sleep, and food diary will be measured daily till 6 months	—

Measure

Time frame

To study the long-term association between dysmenorrhea and HRV To study the impact of Arogya Raksha Panchatantra on primary dysmenorrhoea symptoms using a retrospective symptom scale (RSS). To study the effects of the basic five lifestyle principles on quality of life using the SF-12 health questionnaire. To study the effects of the basic five lifestyle principles on self-efficacy using a Generalized self-efficacy questionnaire. To study the effects of the basic five lifestyle principles on sleep quality and daytime performance using the Epworth daytime sleepiness scale. To document enduring health benefits of the basic five lifestyle principles in absenteeism, frequency of illness, academic performance among the study participants. To understand the adherence of the study participants to arogya raksha panchatantras. Timepoint: SF12, RSS, sleep scale, Efficacy questionnaire will be measured at baseline , after 3 months of intervention and at 6 months follow up Self-reported VAS, sleep, and food diary will be measured daily till 6 months

—

Countries

India

Contacts

Public ContactKarishma silwal

Sant Hirdaram Medical College of Naturopathy and Yogic Sciences for Women, Bhopal

drpradeep18bnys@gmail.com9823262179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026